Buy Satsuma Pharmaceuticals Inc Stock | STSA Stock Price & Latest News | Public.com
STSA

Satsuma Pharmaceuticals Inc

$0.00 (0.00%)Today
    View Satsuma Pharmaceuticals Inc (STSA) stock trends here

    About STSA

    Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraine. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotam...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.24
    -0.48
    -0.72
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.41

    Actual EPS
    Q2 2021

    Stats

    Market Cap$152.91M
    Volume10.07k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$36.10
    1 Year Low$3.50
    Open$4.80
    High$5.00
    Low$4.77

    Buy any stock with any amount of money.

    Download the App
    Download the app